bullish

Island Pharmaceuticals Ltd - Aligning with the US Government

128 Views10 Mar 2026 09:00
Issuer-paid
SUMMARY
  • Island Pharmaceuticals Ltd (ASX:ILA) is an antiviral therapeutics company targeting infectious diseases.
  • The company announced on 4 March 2026 that it had reached an agreement with two strategic US-based biodefence institutions in connection with ILA’s Galidesivir programme.
  • The three-year Cooperative Research and Development Agreement (CRADA) is a trilateral agreement with the US Army Medical Research Institute (USAMRIID) and The Geneva Foundation.
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
chart-bar
Price Chart(Sign Up to Access)
analytics-chart
  • Island Pharmaceuticals Ltd - Aligning with the US Government
    10 Mar 2026
x